An interventional study of Standardized Fortification and Adjustable Fortification in Very Preterm Maturity of Infant and Very Low Birth Weight Infant, sponsored by Children's National Research Institute. Recruiting at 1 site in United States. Open to participants aged Up to 4 Weeks. Per ClinicalTrials.gov, last updated 2025-07-11.
Sponsored by Children's National Research Institute · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Birth Weight with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Birth Weight · United States.
Among the 32 studies in Birth Weight with a site in United States, this one is the 6th largest by planned enrollment of the 19 interventional ones that give a count, is one of 3 that started in 2024, is one of 15 with no phase, and was the 28th registered.
185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.
Browse Birth Weight studies →6 of the 32 studies in Birth Weight with a site in United States are open now. Recruiting first, the newest first:
University of Massachusetts, Worcester · Sites in United States
Ages 18+ · Women only
University of Tennessee · Sites in United States
Ages 1 min–6 hrs
Washington University School of Medicine · Sites in United States
Ages 14–55 · Women only · Healthy volunteers
The Hospital for Sick Children · Sites in United States, Canada
Ages 1 hrs–21 days
Vermont Oxford Network · Sites in United States
Ages up to 28 days
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 18 Birth Weight studies recruiting now, 7 (39%) set no upper age limit and 11 (61%) stop at 75 or younger; 11 take children under 18; 4 take healthy volunteers.
This study: Up to 4 Weeks · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 1990; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 150 is below the median of 170 across 117 interventional studies indexed under Birth Weight.
Median enrollment 49 across the 19 interventional studies, 208 across the 13 observational. Of the 23 that completed or were terminated, 3 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 32 have an industry lead sponsor. The 10 most frequent:
Children's National Research Institute is the lead sponsor of 127 studies on the registry; 45 are open to participants now.
Children's National Research Institute has 1 study filed under Birth Weight — fewer than ten, so there is no comparison to draw.
1 of the studies in Birth Weight with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06870981The Hospital for Sick ChildrenOptimizing Nutrition and Milk (Opti-NuM) Project | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 32 studies in Birth Weight with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Human milk has several well-established benefits but does not adequately meet the increased nutritional demands of the growing preterm infant, necessitating additional nutrient supplementation in a process known as fortification. In U.S. neonatal intensive care units (NICUs), human milk is primarily supplemented using standardized fortification, in which a multicomponent fortifier is added to human milk to achieve assumed nutrient content based on standard milk reference values. However, this method does not account for the significant variability in human milk composition or in preterm infant metabolism, and up to half of all very premature infants experience poor growth and malnutrition using current nutritional practices. Poor postnatal growth has adverse implications for the developing preterm brain and long-term neurodevelopment.
Recent advances allow for individualized methods of human milk fortification, including adjustable and targeted fortification. Adjustable fortification uses laboratory markers of protein metabolism (BUN level) to estimate an infant's protein requirements. In targeted fortification, a milk sample is analyzed to determine its specific macronutrient and energy content, with additional macronutrient supplementation provided as needed to achieve goal values. Emerging data suggest that both methods are safe and effective for improving growth, however information on their comparable efficacy and neurodevelopmental implications are lacking, particularly using advanced quantitative brain MRI (qMRI) techniques.
Through this prospective, randomized-controlled trial, the investigators will compare the impact of individualized human milk fortification on somatic growth and neurodevelopment in preterm infants. Infants will be randomized to receive one of three nutritional interventions: standardized (control group), adjustable, or targeted human milk fortification. Infants will undergo their assigned nutritional intervention until term-equivalent age or discharge home, whichever is achieved first. Brain qMRI will be performed at term-corrected age, and neurodevelopmental follow-up will be performed through 5 years of age.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All study participants will undergo feed advancement and fortification with liquid, bovine-based human milk fortifier (HMF) to an assumed human milk content of 24kcal/oz per the Children's National Hospital NICU standardized clinical feeding protocol. The same milk fortification recipes are utilized for mother's own milk (MOM) and donor human milk (DHM). Each infant's growth trajectory is monitored (weight, length, and head circumference) with dietary modifications performed as needed based on growth parameters. Growth failure is defined as a decline in weight-for-age z-score by greater than 1 standard deviation (\>1 SD) beginning 1 week after reaching goal fortified feeds. For infants who demonstrate growth failure, Step 1 will be to add medium chain triglyceride (MCT) oil. If growth remains sub-optimal, Step 2 will be to add liquid protein.
Dietary Supplement: Standardized Fortification
Adjustable fortification will begin 1 week after tolerating goal feeds of standardized fortification. Blood urea nitrogen (BUN) level as a marker of protein metabolism will be measured weekly, and supplementation with liquid protein will be adjusted as necessary to maintain a goal BUN level between 9-14mmol/dL, up to a maximum assumed protein intake of 4.5 g/kg/day. Liquid protein supplementation will be modified as follows: * BUN Level \<9 mmol/dL: Increase by 0.5g/kg/day * BUN Level 9-14 mmol/dL: No change * BUN Level \>14 mmol/dL: Decrease by 0.25g/kg/day * BUN Level \>20 mmol/dL: Hold for 1 week and re-assess Growth failure is defined as a decline in weight-for-age z-score by \>1 SD beginning 1 week after achieving BUN within goal range from adjustable fortification. For infants who demonstrate growth failure, MCT oil will be added and increased weekly as needed.
Dietary Supplement: Standardized Fortification · Dietary Supplement: Adjustable Fortification
Targeted fortification will begin 1 week after tolerating goal feeds of standardized fortification. Additional supplementation with liquid protein and/or MCT oil will be provided based on twice weekly milk analysis using a mid-infrared human milk analyzer in order to meet macronutrient (carbohydrate, protein, lipid) and energy intake goals per pediatric nutrition guidelines (protein 4-4.5g/kg/day, fat 6-8g/kg/day, energy 120-130kcal/kg/day). Growth failure is defined as a decline in weight-for-age z-score by \>1 SD beginning 1 week after receiving macronutrient and energy intake within goal range from targeted fortification. For infants with growth failure, total energy intake will be increased with additional protein and/or MCT oil supplementation. Energy intake may be increased weekly as needed.
Dietary Supplement: Standardized Fortification · Dietary Supplement: Adjustable Fortification
Fortification with liquid, bovine-based HMF to assumed human milk content of 24kcal/oz
Additional liquid protein supplementation to maintain serum BUN levels within goal range (9-14mmol/dL)
Additional liquid protein and/or MCT oil supplementation to maintain protein, fat, and energy intake within goal range based upon mid-infrared human milk analysis
Weight Gain Velocity
Weight gain velocity (grams per kilogram per day)
Time frame: Study enrollment through nutritional intervention endpoint (term-equivalent age (40 weeks PMA [postmenstrual age]) or discharge home, whichever is achieved first)
Length Growth Velocity
Length growth velocity (centimeters per week)
Time frame: Study enrollment through nutritional intervention endpoint (term-equivalent age (40 weeks PMA [postmenstrual age]) or discharge home, whichever is achieved first)
Head Circumference Growth Velocity
Head circumference growth velocity (centimeters per week)
Time frame: Study enrollment through nutritional intervention endpoint (term-equivalent age (40 weeks PMA [postmenstrual age]) or discharge home, whichever is achieved first)
Total and Regional Brain Volumes
Total and regional (cortical and deep gray matter, white matter, amygdala-hippocampus, brainstem, cerebellum) brain volumes by MRI
Time frame: Term-equivalent age (38 to 41 weeks postmenstrual age)
Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS)
Summary scores in 13 different domains (habituation, attention, handling, self-regulation, arousal, excitability, lethargy, hypertonicity, hypotonicity, non-optimal reflex, asymmetric reflex, quality of movement, stress)
Time frame: Term-equivalent age (38 to 41 weeks postmenstrual age)
Mullen Scales of Early Learning (MSEL)
Composite score as well as 5 subscores: gross motor, fine motor, visual reception, receptive language, and expressive language (reported as standardized t-scores, higher score indicates a better outcome, mean standardized t-score of 50 with standard deviation of 10)
Time frame: 18 months corrected age
Mullen Scales of Early Learning (MSEL)
Composite score as well as 5 subscores: gross motor, fine motor, visual reception, receptive language, and expressive language (reported as standardized t-scores, higher score indicates a better outcome, mean standardized t-score score of 50 with standard deviation of 10)
Time frame: 36 months (3 years) of age
Wechsler Preschool and Primary Scale of Intelligence (4th edition) (WPPSI-IV)
Five primary indices: verbal comprehension, visual spatial, working memory, fluid reasoning, and processing speed (higher score indicates better performance, score range 40 to 160)
Time frame: 60 months (5 years) of age
Differential Abilities Scale (2nd edition)-(DAS-II)
\*For children with significant delays who may be unable to reach basal scores on the WPPSI-IV Early years core battery: verbal, nonverbal, and spatial reasoning subtests (higher score indicates better performance, score range 40-170)
Time frame: 60 months (5 years) of age
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Jan 2034, 119 months after the start.
Of 43 non-industry interventional studies with no phase under Birth Weight, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 36. This study's planned 119 months is above that.
Counting every sponsor, half of 44 studies reached it within 19 months; a quarter within 15 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's National Research Institute →